BD FACSDiscover™ S8 Cell Sorter with BD
CellView™ Image Technology First to Combine Spectral Flow Cytometry
with Sort-Capable Imaging
FRANKLIN
LAKES, N.J., June 3, 2022
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a
leading global medical technology company, today announced it will
introduce new cell sorting technology at the International Society
for Advancement of Cytometry (ISAC) CYTO 2022 conference
June 3-7 that enables researchers to
see and sort cells at speeds never before possible, which creates
the potential to transform research and cell-based therapeutic
development across a range of fields such as virology and oncology,
as well as numerous disease states.
The new BD FACSDiscover™ S8 Cell Sorter features the
breakthrough BD CellView™ Image Technology profiled earlier this
year on the cover of the journal Science. It is the first
cell sorter to combine advanced spectral flow cytometry with
sort-capable image analysis that will potentially enable
researchers to yield more accurate data and sort cells that
previously could not be identified.
"This advancement in cell sorting fills a longstanding gap in
biomedical research by enabling scientists to perform
high-parameter experiments while rapidly viewing and sorting cells
with specific, visualizable traits of interest," said Dr.
Xin Maggie Wang, director of
scientific operations, Westmead Institute for Medical Research.
"For researchers doing spectral flow cytometry, actually seeing the
cells you're interacting with gives you greater confidence in
results and enables you to see cells in a way never possible
before, and answer questions that may have been previously
inconceivable."
Cell sorting through spectral flow cytometry is a cutting-edge
technique that captures the full spectrum signal emitted by sample
preparations instead of specific bands as with traditional flow
cytometry, letting scientists sort cells using more parameters to
better understand human health, disease and treatment.
The BD FACSDiscover™ S8 Cell Sorter combines advanced spectral
flow cytometry with the novel BD CellView™ Image Technology, which
captures images of individual cells flowing through the system and
sorts them based on detailed microscopic image analysis of each one
at high sort speeds. This combination enables scientists to gain
more accurate insights on cell populations and characteristics that
can be visually confirmed in real time, and interrogate and sort
cells that could not be identified before, all in a simplified
experimental workflow. The BD FACSDiscover™ S8 Cell Sorter is the
first BD instrument to feature BD CellView™ Image Technology.
"By combining the power of high-parameter spectral flow
cytometry with this unprecedented picture of a cell and its inner
workings, we are defining a new standard in cell sorting and
putting the power of the cell in the hands of the researcher," said
Puneet Sarin, worldwide president of
BD Biosciences. "The BD FACSDiscover™ S8 Cell Sorter with BD
CellView™ Image Technology represents the next chapter in the BD
legacy of flow cytometry innovation and leadership, and together
with complementary tools like our new spectrally optimized BD
Horizon RealYellow™ and RealBlue™ Reagents, we are excited to see
how the scientific community will use it to achieve breakthrough
discoveries in less time and with greater confidence, as well as
uncover new applications that can help shape the future of
health."
More information about the BD FACSDiscover™ S8 Cell Sorter is
available at the CYTO 2022 conference, through BD sales
representatives, and at bdbiosciences.com/s8.
About BD
BD is one of the largest global medical
technology companies in the world and is advancing the world of
health™ by improving medical discovery, diagnostics and the
delivery of care. The company supports the heroes on the frontlines
of health care by developing innovative technology, services and
solutions that help advance both clinical therapy for patients and
clinical process for health care providers. BD and its 75,000
employees have a passion and commitment to help enhance the safety
and efficiency of clinicians' care delivery process, enable
laboratory scientists to accurately detect disease and advance
researchers' capabilities to develop the next generation of
diagnostics and therapeutics. BD has a presence in virtually every
country and partners with organizations around the world to address
some of the most challenging global health issues. By working in
close collaboration with customers, BD can help enhance outcomes,
lower costs, increase efficiencies, improve safety and expand
access to health care. For more information on BD, please visit
bd.com or connect with us on LinkedIn at
www.linkedin.com/company/bd1/ and Twitter @BDandCo.
Contacts:
Media:
|
Investors:
|
Troy
Kirkpatrick
|
Francesca
DeMartino
|
VP, Public
Relations
|
SVP, Head of Investor
Relations
|
858.617.2361
|
201.847.5743
|
troy.kirkpatrick@bd.com
|
francesca.demartino@bd.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bd-unveils-worlds-first-spectral-cell-sorter-with-high-speed-imaging-technology-that-sorts-cells-based-on-visual-characteristics-301560725.html
SOURCE BD (Becton, Dickinson and Company)